ConductScience.org, home

Paper319355

Controlled comparison of amikacin and gentamicin.

Smith CR and 4 others. N Engl J Med, 1977. Cited by 162 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Controlled comparison of amikacin and gentamicin. Papers, record 319355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/319355

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Controlled comparison of amikacin and gentamicin.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
8.72
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith CRC R
2Baughman KLK L
3Edwards CQC Q
4Rogers JFJ F
5Lietman PSP S

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
Bacterial InfectionsMajor topic
GentamicinsMajor topic
KanamycinMajor topic
Adult
Aged
Bacteria
Clinical Trials as Topic
Drug Evaluation
Drug Resistance, Microbial
Hearing Disorders
Humans
Kidney
Middle Aged
Prospective Studies
Sepsis
Urinary Tract Infections

Source PubMed

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
37,238,307Evaluation of the Utilization of Near-Infrared Fluorescent Contrast Agent ASP5354 for In Vivo Ureteral Identification in Renal Diseases Using Rat Models of Gentamicin-Induced Acute Kidney Injury.Diagnostics (Basel)2023https://conductscience.org/library/papers/37238307PubMed
34,975,247Antimicrobial Resistance in Enterobacteriaceae Bacteria Causing Infection in Trauma Patients: A 5-Year Experience from a Tertiary Trauma Center.J Lab Physicians2021https://conductscience.org/library/papers/34975247PubMed
25,395,343Drug-induced acute kidney injury in children.Br J Clin Pharmacol2015https://conductscience.org/library/papers/25395343PubMed
24,673,698Inhaled antibiotics for lower airway infections.Ann Am Thorac Soc2014https://conductscience.org/library/papers/24673698PubMed
24,250,429The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients.Iran J Pharm Res2011https://conductscience.org/library/papers/24250429PubMed
22,967,486Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin.Hear Res2012https://conductscience.org/library/papers/22967486PubMed
19,285,126Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways.Hear Res2009https://conductscience.org/library/papers/19285126PubMed
18,228,043Nephrotoxicity as a cause of acute kidney injury in children.Pediatr Nephrol2008https://conductscience.org/library/papers/18228043PubMed
10,146,946Methods of minimising the cost of aminoglycoside therapy to hospitals.Pharmacoeconomics1993https://conductscience.org/library/papers/10146946PubMed
7,857,625Experimental, clinical and preventive aspects of ototoxicity.Eur Arch Otorhinolaryngol1994https://conductscience.org/library/papers/7857625PubMed
7,654,476Aminoglycosides--50 years on.Br J Clin Pharmacol1995https://conductscience.org/library/papers/7654476PubMed
7,577,399Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.Pediatr Nephrol1995https://conductscience.org/library/papers/7577399PubMed
7,419,794Which aminoglycoside?Intensive Care Med1980https://conductscience.org/library/papers/7419794PubMed
7,409,887Evaluation of amikacin dosage regimes in the low and very low birthweight newborn.Infection1980https://conductscience.org/library/papers/7409887PubMed
7,399,713Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis.Infection1980https://conductscience.org/library/papers/7399713PubMed
7,294,770Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7294770PubMed
7,247,354Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247354PubMed
7,036,923Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.Ann Surg1982https://conductscience.org/library/papers/7036923PubMed
6,997,210Therapeutic drug monitoring of aminoglycoside antibiotics.Infection1980https://conductscience.org/library/papers/6997210PubMed
6,994,638Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6994638PubMed

See all 59 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/319355

GET https://conductscience.org/api/papers/v1/319355/cited_by?page=2